CVE-2024-10476
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited,...
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.
Attack profile
How easy it is to exploit
- Attack vector
- Adjacent network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
CVE List Score used
8.0
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.
- Record
CVE-2024-10476- CVSS 3.1
- 8.0 High
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-1392
- Updated
- 2026-11-02
EUVDEUVD-2024-33567
8.0
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.
- Record
EUVD-2024-33567- CVSS 3.1
- 8.0 High
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Updated
- 2026-11-03
GitHub AdvisoriesGHSA-2qgh-37rm-mv6x
8.0
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited,...
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.
- Record
GHSA-2qgh-37rm-mv6x- CVSS 3.1
- 8.0 High
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-1392
- Updated
- 2026-11-02
NVD
8.0
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.
- Record
CVE-2024-10476- CVSS 3.1
- 8.0 High
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-1392
- Updated
- 2026-11-02
Affected products
- becton dickinson & co bd bactec™ blood culture system
- becton dickinson & co bd cor™ system
- becton dickinson & co bd epicenter™ microbiology data management system
- becton dickinson & co bd max™ system
- becton dickinson & co bd phoenix™ m50 automated microbiology system
- becton dickinson & co bd synapsys™ informatics solution
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases, published | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2024-10476 is a high vulnerability (CVSS 8.0) in Becton Dickinson & Co Bd Bactec™ Blood Culture System, published December 17, 2024. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.24%, the 14th percentile. No source names a fixed version.